NCT02150954

Brief Summary

The purpose of this research study is to compare induction of labor using a foley catheter bulb with a low dose of oxytocin versus a foley catheter bulb with an increasing dose of oxytocin. A foley catheter bulb with or without oxytocin is a common method of labor induction in patients whose cervix is not significantly dilated or thinned out (effaced). Oxytocin (pitocin) is a medicine used to increase the number and strength of the womb's contractions.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Dec 2007

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
5.2 years until next milestone

First Submitted

Initial submission to the registry

May 23, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 30, 2014

Completed
2 months until next milestone

Results Posted

Study results publicly available

July 23, 2014

Completed
Last Updated

October 26, 2023

Status Verified

June 1, 2014

Enrollment Period

1.2 years

First QC Date

May 23, 2014

Results QC Date

June 24, 2014

Last Update Submit

October 24, 2023

Conditions

Keywords

induction of laborpitocinfoley bulb

Outcome Measures

Primary Outcomes (2)

  • Time to the Second Stage of Labor

    The second stage of labor was defined as the time from complete cervical dilation to delivery of the fetus.

    foley bulb placement until second stage of labor (during admission for delivery, up to approximately 4 days)

  • Time to Delivery

    Time from foley balloon placement until neonate delivery

    foley bulb placement until delivery (during admission for delivery, up to approximately 4 days)

Secondary Outcomes (7)

  • Rate of Cesarean Delivery

    during admission for delivery, up to approximately 4 days

  • Time to Active Labor

    during admission for delivery, up to approximately 4 days

  • Time to Foley Expulsion or Removal

    foley bulb placement until removal, up to 10 hours

  • Incidence of Uterine Hyperstimulation

    during admission for delivery, up to approximately 4 days

  • Neonatal Outcome: Birthweight

    at time of birth (0 to 1 hour)

  • +2 more secondary outcomes

Study Arms (2)

foley bulb induction with low dose pitocin

ACTIVE COMPARATOR

Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.

Drug: pitocin

foley bulb with standard incremental pitocin infusion protocol

ACTIVE COMPARATOR

Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.

Drug: pitocin

Interventions

Also known as: oxytocin
foley bulb induction with low dose pitocinfoley bulb with standard incremental pitocin infusion protocol

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a singleton pregnancy
  • Term pregnancy (\> 37 weeks gestation)
  • Age ≥ 18 years
  • Bishop score \< 5
  • Contractions \< 6/hr
  • Reassuring fetal heart tracing

You may not qualify if:

  • Rupture of membranes
  • Antepartum bleeding
  • Fetal death
  • Placenta previa or low lying placenta
  • Active genital herpes infection
  • Previous use of an induction or preinduction agent during the current pregnancy
  • EFW \>4500 grams
  • Non reassuring fetal testing
  • Inability to pass foley through cervix
  • Prior cesarean section

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Oxytocin

Intervention Hierarchy (Ancestors)

Pituitary Hormones, PosteriorPituitary HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins

Results Point of Contact

Title
Chad Grotegut , MD
Organization
Duke University Medical Center

Study Officials

  • Chad Grotegut, MD

    Duke University

    PRINCIPAL INVESTIGATOR
  • Brennan Fitzpatrick, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2014

First Posted

May 30, 2014

Study Start

December 1, 2007

Primary Completion

March 1, 2009

Study Completion

March 1, 2009

Last Updated

October 26, 2023

Results First Posted

July 23, 2014

Record last verified: 2014-06